Literature DB >> 18614744

Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction.

Qi Sun1, Jing Ma, Hannia Campos, Kathryn M Rexrode, Christine M Albert, Dariush Mozaffarian, Frank B Hu.   

Abstract

BACKGROUND: Whereas dietary intake of long-chain n-3 fatty acids has been associated with risk of nonfatal myocardial infarction (MI), few studies have examined the relation for blood concentrations.
OBJECTIVE: We aimed to investigate the effect of long-chain n-3 fatty acids in blood on the risk of nonfatal MI.
DESIGN: Baseline blood samples were collected from 32 826 participants of the Nurses' Health Study in 1989-1990, among whom 146 incident cases of nonfatal MI were ascertained during 6 y of follow-up and matched with 288 controls.
RESULTS: After multivariate adjustment, the relative risks (95% CI) comparing the highest with the lowest quartiles in plasma were 0.23 (0.09, 0.55; P for trend = 0.001) for eicosapentaenoic acid (EPA), 0.40 (0.20, 0.82; P for trend = 0.004) for docosapentaenoic acid (DPA), and 0.46 (0.18, 1.16; P for trend = 0.07) for docosahexaenoic acid (DHA). The associations for these fatty acids in erythrocytes were generally weaker and nonsignificant. In contrast to EPA and DHA, blood concentrations of DPA were not correlated with dietary consumption of n-3 fatty acids. Higher plasma concentrations of EPA, DPA, and DHA were associated with higher plasma concentrations of HDL cholesterol and lower concentrations of triacylglycerol and inflammatory markers.
CONCLUSIONS: Higher plasma concentrations of EPA and DPA are associated with a lower risk of nonfatal MI among women. These findings may partly reflect dietary consumption but, particularly for DPA, may indicate important risk differences based on metabolism of long-chain n-3 fatty acids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614744      PMCID: PMC6598701          DOI: 10.1093/ajcn/88.1.216

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  48 in total

Review 1.  Fatty acid modulation of endothelial activation.

Authors:  R De Caterina; J K Liao; P Libby
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

2.  Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China.

Authors:  J M Yuan; R K Ross; Y T Gao; M C Yu
Journal:  Am J Epidemiol       Date:  2001-11-01       Impact factor: 4.897

3.  Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands.

Authors:  C M Oomen; E J Feskens; L Räsänen; F Fidanza; A M Nissinen; A Menotti; F J Kok; D Kromhout
Journal:  Am J Epidemiol       Date:  2000-05-15       Impact factor: 4.897

4.  Serum free fatty acid pattern and risk of myocardial infarction: a case-control study.

Authors:  P Yli-Jama; H E Meyer; J Ringstad; J I Pedersen
Journal:  J Intern Med       Date:  2002-01       Impact factor: 8.989

5.  Blood levels of long-chain n-3 fatty acids and the risk of sudden death.

Authors:  Christine M Albert; Hannia Campos; Meir J Stampfer; Paul M Ridker; JoAnn E Manson; Walter C Willett; Jing Ma
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

6.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

Authors: 
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

7.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women.

Authors:  Frank B Hu; Leslie Bronner; Walter C Willett; Meir J Stampfer; Kathryn M Rexrode; Christine M Albert; David Hunter; JoAnn E Manson
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

8.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

Authors:  Heiner C Bucher; Peter Hengstler; Christian Schindler; Gabriela Meier
Journal:  Am J Med       Date:  2002-03       Impact factor: 4.965

9.  Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study.

Authors:  Dariush Mozaffarian; Rozenn N Lemaitre; Lewis H Kuller; Gregory L Burke; Russell P Tracy; David S Siscovick
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

10.  n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.

Authors:  Rozenn N Lemaitre; Irena B King; Dariush Mozaffarian; Lewis H Kuller; Russell P Tracy; David S Siscovick
Journal:  Am J Clin Nutr       Date:  2003-02       Impact factor: 7.045

View more
  53 in total

Review 1.  (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Nutr       Date:  2012-01-25       Impact factor: 4.798

2.  Association of red blood cell n-3 polyunsaturated fatty acids with plasma inflammatory biomarkers among the Quebec Cree population.

Authors:  M-È Labonté; E Dewailly; M Lucas; P Couture; B Lamarche
Journal:  Eur J Clin Nutr       Date:  2014-07-16       Impact factor: 4.016

3.  Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study.

Authors:  Dariush Mozaffarian; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Donna Spiegelman; Frank M Sacks; Eric B Rimm; David S Siscovick
Journal:  Ann Intern Med       Date:  2011-08-02       Impact factor: 25.391

Review 4.  Coronary heart disease prevention: nutrients, foods, and dietary patterns.

Authors:  Shilpa N Bhupathiraju; Katherine L Tucker
Journal:  Clin Chim Acta       Date:  2011-05-07       Impact factor: 3.786

5.  Joint effects of fatty acid desaturase 1 polymorphisms and dietary polyunsaturated fatty acid intake on circulating fatty acid proportions.

Authors:  Juan Juan; Hongyan Huang; Xia Jiang; Andres V Ardisson Korat; Mingyang Song; Qi Sun; Walter C Willett; Majken K Jensen; Peter Kraft
Journal:  Am J Clin Nutr       Date:  2018-05-01       Impact factor: 7.045

6.  Erythrocyte stearidonic acid and other n-3 fatty acids and CHD in the Physicians' Health Study.

Authors:  Chisa Matsumoto; Nirupa R Matthan; Jemma B Wilk; Alice H Lichtenstein; J Michael Gaziano; Luc Djoussé
Journal:  Br J Nutr       Date:  2012-10-26       Impact factor: 3.718

7.  Myocardial infarction does not affect fatty-acid profiles in rats.

Authors:  Gregory C Shearer; Jinghai Chen; Yuefeng Chen; William S Harris
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-09-22       Impact factor: 4.006

8.  Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.

Authors:  Michael R Flock; Ann C Skulas-Ray; William S Harris; Trent L Gaugler; Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-07-17       Impact factor: 4.006

9.  Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study.

Authors:  Ramin Farzaneh-Far; William S Harris; Sachin Garg; Beeya Na; Mary A Whooley
Journal:  Atherosclerosis       Date:  2008-12-14       Impact factor: 5.162

10.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.